相关实验视频

Updated: Jun 28, 2025

Prehospital Thrombolysis: A Manual from Berlin

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

在中风患者中偶发性肺栓塞的血栓溶解

Patrick Silveira¹, Justin McCloskey¹, Mohammad Kassar¹

¹Department of Radiology, West Virginia University Hospital, 1 Medical Center Drive, PO Box 9235 Morgantown, WV, USA.

Radiology case reports

|April 22, 2024

概括

这项案例研究显示,88岁的急性缺血性中风 (AIS) 和偶发性肺栓塞 (PE) 的男性成功接受了血栓消毒疗法,这表明这两种情况的结果都是有利的.

科学领域:

心脏病学心脏病学
神经学神经学
血管医学血管医学

背景情况:

急性缺血性中风 (AIS) 和肺栓塞 (PE) 是导致死亡和残疾的重要原因.
分享的风险因素增加了AIS和PE同时发生的可能性.
肺栓塞可以在AIS的诊断工作中偶然检测到.

研究的目的:

报告一例成功进行血栓解压疗法的病例,患者既患有急性缺血性中风,也患有偶发性肺栓塞.
要突出与血栓溶解并发AIS和PE的管理.
在复杂的临床场景中证明有利的结果.

主要方法:

一个88岁的男性患者的病例报告.
对急性缺血性中风 (AIS) 的诊断.
在AIS工作过程中偶然诊断出肺栓塞 (PE).
对于这两种情况,给予血栓消毒疗法.

主要成果:

患者接受了血栓消毒疗法.
在急性缺血性中风和肺栓塞方面都取得了有利的临床结果.
该案例说明了血栓溶解在管理并发AIS和PE方面的潜在好处.

结论:

血栓溶解药物治疗可以为患有急性缺血性中风和偶发性肺栓塞的患者提供安全有效的治疗方法.
及时诊断和同时发生的血栓栓塞事件的治疗对于改善患者的治疗结果至关重要.
这一案例强调了在评估重大血管事件时考虑和管理并存疾病的重要性.

关键词:

肺栓塞肺栓塞是一种肺栓塞.一次性中风,中风.太尼克特代替了太尼克特.血栓溶解药物治疗的方法

更多相关视频

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.